Rankings
▼
Calendar
SRPT FY 2023 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.2B
+33.3% YoY
Gross Profit
$1.1B
87.9% margin
Operating Income
-$268M
-21.5% margin
Net Income
-$536M
-43.1% margin
EPS (Diluted)
$-5.80
Cash Flow
Operating Cash Flow
-$501M
Free Cash Flow
-$588M
Stock-Based Comp.
$183M
Balance Sheet
Total Assets
$3.3B
Total Liabilities
$2.4B
Stockholders' Equity
$859M
Cash & Equivalents
$428M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.2B
$933M
+33.3%
Gross Profit
$1.1B
$793M
+37.8%
Operating Income
-$268M
-$536M
+50.1%
Net Income
-$536M
-$703M
+23.8%
← Q4 2022
All Quarters
Q1 2023 →